The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression

Farnesoid X receptor (FXR) controls the expression of critical genes in bile acid and cholesterol homeostasis. To study FXR and to develop a regulator of cholesterol, some nonsteroidal and steroidal ligands have been found in addition to endogenous ligands for FXR. In this study, we discovered five...

Full description

Bibliographic Details
Main Authors: Takuo Suzuki, Norimasa Tamehiro, Yoji Sato, Tetsu Kobayashi, Akiko Ishii-Watabe, Youichi Shinozaki, Tomoko Nishimaki-Mogami, Toshihiro Hashimoto, Yoshinori Asakawa, Kazuhide Inoue, Yasuo Ohno, Teruhide Yamaguchi, Toru Kawanishi
Format: Article
Language:English
Published: Elsevier 2008-01-01
Series:Journal of Pharmacological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S134786131931415X
_version_ 1818976012710445056
author Takuo Suzuki
Norimasa Tamehiro
Yoji Sato
Tetsu Kobayashi
Akiko Ishii-Watabe
Youichi Shinozaki
Tomoko Nishimaki-Mogami
Toshihiro Hashimoto
Yoshinori Asakawa
Kazuhide Inoue
Yasuo Ohno
Teruhide Yamaguchi
Toru Kawanishi
author_facet Takuo Suzuki
Norimasa Tamehiro
Yoji Sato
Tetsu Kobayashi
Akiko Ishii-Watabe
Youichi Shinozaki
Tomoko Nishimaki-Mogami
Toshihiro Hashimoto
Yoshinori Asakawa
Kazuhide Inoue
Yasuo Ohno
Teruhide Yamaguchi
Toru Kawanishi
author_sort Takuo Suzuki
collection DOAJ
description Farnesoid X receptor (FXR) controls the expression of critical genes in bile acid and cholesterol homeostasis. To study FXR and to develop a regulator of cholesterol, some nonsteroidal and steroidal ligands have been found in addition to endogenous ligands for FXR. In this study, we discovered five bile acid derivatives (methyl cholate, methyl deoxycholate, 5β-cholanic acid, 5β-cholanic acid-7α,12α-diol, and NIHS700) and two natural products (marchantin A and marchantin E) that activated FXR in the reporter assay. These compounds activated FXR to a high level comparable to the most potent endogenous bile acid, chenodeoxycholic acid, although it was not predicted from their structures; five of them were similar to the lower potency bile acids, and two were structurally much different from bile acids. The elevation levels of reporter gene expression by some of the screened compounds were varied in Cos-7, HepG2, HuH-7, and Caco-2 cells. These compounds also controlled the expression of genes regulated by FXR, and some of the compounds regulated these genes in a cell-type–specific and/or gene-selective fashion. Therefore, molecular design of the compounds can cause selective modulation of the expression of FXR target genes. Keywords:: farnesoid X receptor (FXR), reporter assay, ginkgolic acid, marchantin, cell-type–specific modulation
first_indexed 2024-12-20T16:05:05Z
format Article
id doaj.art-54ff935b5140480fbae8dfdb6020a717
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-12-20T16:05:05Z
publishDate 2008-01-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-54ff935b5140480fbae8dfdb6020a7172022-12-21T19:34:11ZengElsevierJournal of Pharmacological Sciences1347-86132008-01-011073285294The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene ExpressionTakuo Suzuki0Norimasa Tamehiro1Yoji Sato2Tetsu Kobayashi3Akiko Ishii-Watabe4Youichi Shinozaki5Tomoko Nishimaki-Mogami6Toshihiro Hashimoto7Yoshinori Asakawa8Kazuhide Inoue9Yasuo Ohno10Teruhide Yamaguchi11Toru Kawanishi12Division of Biological Chemistry and Biologicals, Tokyo 158-8501, Japan; Pharmaceuticals and Medical Device Agency, Tokyo 100-0013, Japan; Corresponding author (affiliation #1). tsuzuki@nihs.go.jpDivision of Biosignaling, Tokyo 158-8501, JapanDivision of Cellular and Gene Therapy Products, Tokyo 158-8501, JapanDivision of Biological Chemistry and Biologicals, Tokyo 158-8501, JapanDivision of Biological Chemistry and Biologicals, Tokyo 158-8501, JapanDivision of Pharmacology, National Institute of Health Sciences, Tokyo 158-8501, JapanDivision of Biosignaling, Tokyo 158-8501, JapanFaculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, JapanFaculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 770-8514, JapanGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, JapanDivision of Pharmacology, National Institute of Health Sciences, Tokyo 158-8501, JapanDivision of Biological Chemistry and Biologicals, Tokyo 158-8501, JapanDivision of Biological Chemistry and Biologicals, Tokyo 158-8501, JapanFarnesoid X receptor (FXR) controls the expression of critical genes in bile acid and cholesterol homeostasis. To study FXR and to develop a regulator of cholesterol, some nonsteroidal and steroidal ligands have been found in addition to endogenous ligands for FXR. In this study, we discovered five bile acid derivatives (methyl cholate, methyl deoxycholate, 5β-cholanic acid, 5β-cholanic acid-7α,12α-diol, and NIHS700) and two natural products (marchantin A and marchantin E) that activated FXR in the reporter assay. These compounds activated FXR to a high level comparable to the most potent endogenous bile acid, chenodeoxycholic acid, although it was not predicted from their structures; five of them were similar to the lower potency bile acids, and two were structurally much different from bile acids. The elevation levels of reporter gene expression by some of the screened compounds were varied in Cos-7, HepG2, HuH-7, and Caco-2 cells. These compounds also controlled the expression of genes regulated by FXR, and some of the compounds regulated these genes in a cell-type–specific and/or gene-selective fashion. Therefore, molecular design of the compounds can cause selective modulation of the expression of FXR target genes. Keywords:: farnesoid X receptor (FXR), reporter assay, ginkgolic acid, marchantin, cell-type–specific modulationhttp://www.sciencedirect.com/science/article/pii/S134786131931415X
spellingShingle Takuo Suzuki
Norimasa Tamehiro
Yoji Sato
Tetsu Kobayashi
Akiko Ishii-Watabe
Youichi Shinozaki
Tomoko Nishimaki-Mogami
Toshihiro Hashimoto
Yoshinori Asakawa
Kazuhide Inoue
Yasuo Ohno
Teruhide Yamaguchi
Toru Kawanishi
The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
Journal of Pharmacological Sciences
title The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
title_full The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
title_fullStr The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
title_full_unstemmed The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
title_short The Novel Compounds That Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression
title_sort novel compounds that activate farnesoid x receptor the diversity of their effects on gene expression
url http://www.sciencedirect.com/science/article/pii/S134786131931415X
work_keys_str_mv AT takuosuzuki thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT norimasatamehiro thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT yojisato thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT tetsukobayashi thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT akikoishiiwatabe thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT youichishinozaki thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT tomokonishimakimogami thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT toshihirohashimoto thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT yoshinoriasakawa thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT kazuhideinoue thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT yasuoohno thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT teruhideyamaguchi thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT torukawanishi thenovelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT takuosuzuki novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT norimasatamehiro novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT yojisato novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT tetsukobayashi novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT akikoishiiwatabe novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT youichishinozaki novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT tomokonishimakimogami novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT toshihirohashimoto novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT yoshinoriasakawa novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT kazuhideinoue novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT yasuoohno novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT teruhideyamaguchi novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression
AT torukawanishi novelcompoundsthatactivatefarnesoidxreceptorthediversityoftheireffectsongeneexpression